Tough Trade-Offs — Gardasil in China, Layoffs, and How Merck Talks About Adversity

Merck in 2026 is a company under real pressure — Gardasil sales collapsed 39% in 2025, the company announced 6,000 job cuts and a $3B cost-savings program, the stock has been volatile. This module covers the headwinds candidly and shows candidates how to talk about adversity, layoffs, and resilience in a way that matches how Merck leaders discuss it.